Member access

4-Traders Homepage  >  Shares  >  Tokyo  >  Astellas Pharma Inc    4503   JP3942400007

SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 
Latest news on ASTELLAS PHARMA INC
4d ago ASTELLAS PHARMA : Teams Up with USA Rugby and Men's Health Network to Encourage ..
4d ago ASTELLAS PHARMA : Announces Research Collaboration With Harvard Medical School I..
4d ago ASTELLAS PHARMA : Announces Revision of Package Insert in Japan for XTANDI (enza..
5d ago ASTELLAS PHARMA : Announces Revision of Package Insert in Japan for XTANDI® (enz..
10/17 ASTELLAS PHARMA : Partners with USA Rugby and Men's Health Network
10/16 ASTELLAS PHARMA : and CoMentis to End Agreement to Collaborate on Research, Deve..
10/15 ASTELLAS PHARMA : Patent Issued for Nitrogenous-Ring Acylguanidine Derivative
10/15 ASTELLAS PHARMA : Announces research collaboration with harvard medical school i..
10/14 ASTELLAS PHARMA : ANNOUNCES RESEARCH COLLABORATION WITH HARVARD MEDICAL SCHOOL I..
10/13 ASTELLAS PHARMA : Cytokinetics Announces Development Program Update for CK-21271..
10/10 ASTELLAS PHARMA : promotes employment of disabled workers with Green Supply Supp..
10/08 ASTELLAS PHARMA : promotes employment of people with disabilities by placing the..
10/08 ASTELLAS PHARMA : Investigators at Astellas Pharma, Inc. Describe Findings in Ne..
10/04 ASTELLAS PHARMA : Agensys Assigned Patent
10/04 ASTELLAS PHARMA : Agensys Assigned Patent
10/03 ASTELLAS PHARMA : Brian McLellan Promoted To President Of Astellas Pharma Techno..
09/26 ASTELLAS PHARMA INC : ex-dividend day for interim dividend
09/23 MEDIVATION : and Astellas Pharma: FDA Grants Approval for New Xtandi Indication
09/17 ASTELLAS PHARMA : U.S. FDA Approves New Indication for the Use of XTANDI® enzalu..
09/16 ASTELLAS PHARMA : has been Selected for the Fourth Consecutive Year for the Dow ..
09/16 MEDIVATION : FDA Grants Approval to New Xtandi Indication
09/15 ASTELLAS PHARMA : FDA Oks New Indication for the Use of XTANDI (enzalutamide) Ca..
09/15 ASTELLAS PHARMA : FDA Approves New Indication for the Use of XTANDI (enzalutamid..
09/11 MEDIVATION : ASTELLAS -U.S. FDA Approves New Indication for the Use of XTANDI (e..
09/10 ASTELLAS PHARMA : Patent Issued for Antitumor Agent
09/08 Swiss Stocks Edge Higher, Led By Drug Makers
09/08 ASTELLAS PHARMA : Basilea's partner Astellas receives notification from U.S. FDA..
09/08 ASTELLAS PHARMA : Transfer of Distribution and Termination of Co-promotion for C..
09/07 ASTELLAS PHARMA : Transfer of Distribution and Termination of Co-promotion for C..
09/05 ASTELLAS PHARMA : donates ambulances on First-Aid Day (September 9) Annual donat..
09/04 ASTELLAS PHARMA : Findings from Astellas Pharma, Inc. Broaden Understanding of O..
09/01 ASTELLAS PHARMA : Supports to Flood Relief Efforts in Western Japan
08/28 ASTELLAS PHARMA : Announces Personnel Changes and Organization Changes
08/28 UK cancer drug fund gets extra 160 million pounds
08/27 ASTELLAS PHARMA : Researchers at Astellas Pharma, Inc. Report New Data on Invest..
08/27 ASTELLAS PHARMA : Studies from Astellas Pharma, Inc. Update Current Data on Clin..
08/27 ASTELLAS PHARMA : Announces Personnel Changes and Organization Changes (pdf 85KB..
08/21 AMBIT BIOSCIENCES : Posts 2Q 2014 Results
08/18 AMBIT BIOSCIENCES : Releases 2Q 2014 Results
08/16 ASTELLAS PHARMA : Cancer Research UK and Cancer Research Technology Partner with..
08/14 ASTELLAS PHARMA : Basilea reports 2014 half-year financials ceftobiprole launch ..
08/13 ASTELLAS PHARMA : Cancer Research UK and Cancer Research Technology Join Forces ..
08/13 ASTELLAS PHARMA : Research Data from Astellas Pharma, Inc. Update Understanding ..
08/13 ASTELLAS PHARMA : Ambit Biosciences Announces Second Quarter 2014 Operating Resu..
08/11 ASTELLAS PHARMA : OSI Pharmaceuticals Assigned Patent
08/11 ASTELLAS PHARMA : Cancer research uk and cancer research technology join forces ..
08/08 ASTELLAS PHARMA : Cancer research uk and cancer research technology join forces ..
08/07 ASTELLAS PHARMA : Corporate Whistleblower Center Urges Physicians Who Have Proof..
08/06 ASTELLAS PHARMA : Reports Summarize Nephrology Findings from Astellas Pharma, In..
08/01 ASTELLAS PHARMA : Vical Reports Second Quarter 2014 Financial Results and Progre..
07/28 ASTELLAS PHARMA : US Inc. Pays $7.3 Million to Resolve False Claims Act Allegati..
07/26 ASTELLAS PHARMA : US Inc. Pays $7.3 Million to Resolve False Claims Act Allegati..
07/23 ASTELLAS PHARMA : New Findings on Pelvic Organ Prolapse Described by Investigato..
07/18 ASTELLAS PHARMA : NC to Share in $7.3 Million Medicaid Fraud Settlement from Ast..
07/16 ASTELLAS PHARMA : Study Data from Astellas Pharma, Inc. Update Understanding of ..
07/15 ASTELLAS PHARMA : Submits Supplemental New Drug Application for Irribow/Irribow ..
07/15 ASTELLAS PHARMA : Attorney General Pam Bondi Announces $7.3 Million Settlement w..
07/15 ASTELLAS PHARMA : Attorney General J.B. Van Hollen Announces Astellas Pharma to ..
07/14 ASTELLAS PHARMA : Submits Supplemental New Drug Application for Irribow®/Irribow..
07/12 ASTELLAS PHARMA : Pays $7.3 Million to Resolve False Claims Act Allegations Rela..
07/09 ASTELLAS PHARMA : Submits U.S. New Drug Application for Isavuconazole for the Tr..
07/09 ASTELLAS PHARMA : New Clinical Trials and Studies Study Findings Recently Were R..
07/04 ASTELLAS PHARMA : - Contents of Subscription Rights to Shares (Stock Option Sche..
07/03 ASTELLAS PHARMA : Contents of Subscription Rights to Shares (Stock Option Scheme..
07/01 ASTELLAS PHARMA : in the Americas Names Tatjana Dragovic as VP, Regional Complia..
06/27 ASTELLAS PHARMA : Tatjana Dragovic, J.D., Named Vice President, Regional Complia..
06/26 ASTELLAS PHARMA : -Announcement of an Application for the Additional Indication ..
06/25 ASTELLAS PHARMA : Announcement of an Application for the Additional Indication f..
06/24 ASTELLAS PHARMA : -Notice of Completion of Acquisition of Own Shares (Under the ..
06/23 ASTELLAS PHARMA : Notice of Completion of Acquisition of Own Shares (pdf 62KB)
06/18 ASTELLAS PHARMA : Allotment of Subscription Rights to Shares (Stock Option Schem..
06/13 ASTELLAS PHARMA : UCB - First phase 3 study evaluating Cimzia (certolizumab pego..
06/11 ASTELLAS PHARMA : Protein Sciences Partners File for Marketing Approval of Flubl..
06/03 ASTELLAS PHARMA : OSI Pharmaceuticals Assigned Patent
06/02 ASTELLAS PHARMA : and UMN Announce Submission of Application for Marketing Appro..
1  2  3  4  5Next
Advertisement
Chart
Duration : Period :
Astellas Pharma Inc Technical Analysis Chart | 4503 | JP3942400007 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF